Business · 08/10/2020
FDA Announces Draft Guidance for Breast Cancer Drug Development in Premenopausal Women
The FDA is releasing a draft guidance to help industry stakeholders develop and conduct clinical trials for breast cancer treatments in premenopausal women, aiming to increase participation in these trials.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →